Online inquiry

IVTScrip™ mRNA-Human ARHGEF7, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28622MR)

This product GTTS-WK28622MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGEF7 protein. This product can be used in Gonadal endothelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001113511.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8874
UniProt ID Q14155
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF7, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28622MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14936MR IVTScrip™ mRNA-Human ANKRD7, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD7
GTTS-WK10140MR IVTScrip™ mRNA-Human ADGRF5, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADGRF5
GTTS-WK12500MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAMTS16
GTTS-WK14942MR IVTScrip™ mRNA-Human ANKZF1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKZF1
GTTS-WK23298MR IVTScrip™ mRNA-Human ASB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASB2
GTTS-WK24011MR IVTScrip™ mRNA-Human APLNR, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA APLNR
GTTS-WK21498MR IVTScrip™ mRNA-Human ANKRD11, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD11
GTTS-WK12793MR IVTScrip™ mRNA-Human ADAM22, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM22
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →